Adjuvia Therapeutics

Harnessing the Power of Nature’s Designs

San Francisco, United States · Founded 2023 · $8.0M raised

Headquarters
San Francisco
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Adjuvia Therapeutics is a clinical-stage biopharmaceutical company developing blood-brain-barrier-penetrant nanoparticle therapies for diseases associated with mitochondrial dysfunction. Its lead program, ATI-105, is an oral nanoparticle formulation of astaxanthin designed to address rare and chronic degenerative conditions at their underlying cellular mechanisms. The company is advancing therapies for inherited mitochondrial diseases and evaluating additional chronic-disease indications.

Summary

Adjuvia Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Jul 2026.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedJul 2026
$8.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adjuvia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/adjuvia-therapeutics"><img src="https://indexed.vc/api/badge/company/adjuvia-therapeutics" alt="Adjuvia Therapeutics on Indexed.vc" width="260" height="76" /></a>